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OBJECTIVES We sought to develop and evaluate a risk adjustment model for in-hospital mortality
following percutaneous coronary intervention (PCI) procedures using data from a large,
multi-center registry.
BACKGROUND The 1998–2000 American College of Cardiology–National Cardiovascular Data Registry
(ACC–NCDR) dataset was used to overcome limitations of prior risk-adjustment analyses.
METHODS Data on 100,253 PCI procedures collected at the ACC–NCDR between January 1, 1998, and
September 30, 2000, were analyzed. A training set/test set approach was used. Separate
models were developed for presentation with and without acute myocardial infarction (MI)
within 24 h.
RESULTS Factors associated with increased risk of PCI mortality (with odds ratios in parentheses)
included cardiogenic shock (8.49), increasing age (2.61 to 11.25), salvage (13.38) urgent
(1.78) or emergent PCI (5.75), pre-procedure intra-aortic balloon pump insertion (1.68),
decreasing left ventricular ejection fraction (0.87 to 3.93), presentation with acute MI (1.31),
diabetes (1.41), renal failure (3.04), chronic lung disease (1.33); treatment approaches
including thrombolytic therapy (1.39) and non-stent devices (1.64); and lesion characteristics
including left main (2.04), proximal left anterior descending disease (1.97) and Society for
Cardiac Angiography and Interventions lesion classification (1.64 to 2.11). Overall, excellent
discrimination was achieved (C-index  0.89) and application of the model to high-risk
patient groups demonstrated C-indexes exceeding 0.80. Patient factors were more predictive
in the MI model, while lesion and procedural factors were more predictive in the analysis of
non-MI patients.
CONCLUSIONS A risk adjustment model for in-hospital mortality after PCI was successfully developed using
a contemporary multi-center registry. This model is an important tool for valid comparison
of in-hospital mortality after PCI. (J Am Coll Cardiol 2002;39:1104–12) © 2002 by the
American College of Cardiology Foundation
The establishment of quality standards based on patient
outcome data is a rational means for differentiating the
quality of health care in the marketplace. Institutional
variation in the baseline clinical risks of patients precludes
the direct comparison of outcomes across institutions. The
application of risk adjustment methodology to account for
patient differences in these treatment outcomes is impera-
tive for legitimate comparison of institutional results in the
modern era of cardiovascular intervention. Mortality is the
indicator that has been most widely used to evaluate the
quality of cardiac treatment procedures. Cardiac surgeons
addressed the problems associated with the publication in
the late 1980s of unadjusted surgical mortality results in
New York and other states by forming the Society of
Thoracic Surgeons National Database and developing risk
adjustment models for coronary artery bypass graft (CABG)
surgical mortality (1–4). Studies conducted in the Veterans
Administration Health Care System have also demon-
strated that risk adjustment approaches provide a fair
comparison of cardiac surgical outcomes across a broad
spectrum of institutions (5).
There have been numerous efforts in recent years to
incorporate risk adjustment methodology to evaluate differ-
ences in mortality rates for interventional procedures (6–
14). These efforts have been limited by inconsistent defini-
tions of the factors used in the models, small sample sizes,
limited geographic representation, inclusion of programs
that do not necessarily represent the standard of practice
across the country, and patient samples that do not reflect
contemporary percutaneous coronary intervention (PCI)
practice. The goal of the current study was to analyze the
initial experience of the American College of Cardiology–
National Cardiovascular Data Registry (ACC–NCDR) to
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develop a risk-adjusted model for mortality associated with
PCI. The experience of this registry is described in a
companion publication (15). The strengths of the ACC–
NCDR registry experience include the use of standardized
data definitions, data completeness procedures, geographic
and institutional diversity, a large sample size, and analysis
of contemporary PCI practice. These features offer a signif-
icant advantage over previous efforts to develop a risk-
adjustment model for in-hospital mortality after PCI.
METHODS
Data collection. The data collection process has been
described (15). For institutions with submissions passing
the inclusion/exclusion criteria for data completeness, the
first PCI procedure performed during a qualifying hospital-
ization was chosen for analysis. In all, 100,292 procedures
passed the initial screening for inclusion into the risk model
analysis. Because initial screening required that 99% com-
pleteness be achieved on all outcome variables, 39 hospital-
izations were missing data on mortality. These 39 PCI
procedures were excluded from the risk model development,
leaving a total of 100,253 procedures.
Data elements entered into the mortality risk model
included patient demographic data, cardiac risk factors,
coronary revascularization status, anginal status, non-
coronary disease processes, angiographic findings and pro-
cedural variables (Tables 1 through 5). A variable was
constructed combining the lesion codes for the ACC/AHA
type A-B-C lesion class along with the presence or absence
of an occlusion, based on the work of Krone et al. (16). This
classification scheme, referred to as the Society for Cardiac
Angiography and Interventions Lesion Class (SCAI LC),
produces four categories (I, II, III, IV): I—non–type
C/patent; II—type C/patent; III—non–type C/occlusion;
and IV—type C/occlusion. In a preliminary analysis, this
classification system was highly correlated with PCI out-
comes. Congestive heart failure was not included in the
model, because there was a problem with one of the
software vendor packages that allowed out-of-range values
to be included in the database that could not be interpreted.
Statistics. Standard univariate methods were used to gen-
erate odds ratios (ORs) with 95% confidence intervals (CIs)
in evaluating the relationship between individual factors and
mortality. These were tested using Pearson’s chi-square test.
Stepwise logistic regression analysis was performed using
the SPSS 10.1 statistical software (SPSS Inc; Chicago,
Illinois) to assess the independent relationship of all signif-
icant univariate factors with in-hospital mortality. Variables
were entered and removed by a stepwise selection process,
using residual Wald chi-square p values for entry of 0.5 and
0.1 for removal. Improvements in chi-square and maximum
log likelihood stepwise methods, including Hosmer-
Lemeshow goodness of fit chi-square estimates, were used
to evaluate the regression model (17). Model discrimination
was assessed using the area under the receiver operating
characteristic (ROC) or C-index (18). The level of missing
data varied from a low of 0.1% for gender to a high of 26.1%
for left ventricular ejection fraction (LVEF) (Tables 1
through 5). Missing values were assigned values using
multiple imputation methods (19).
Risk model development. Univariate analyses were used
to identify patient demographic and risk factor (Table 1),
cardiac history and anginal status (Table 2), non-coronary
Abbreviations and Acronyms
ACC–NCDR  American College of Cardiology
National Cardiovascular Data Registry
CABG  coronary artery bypass graft surgery
CI  confidence interval
IABP  intra-aortic balloon pump
LAD  left anterior descending
LVEF  left ventricular ejection fraction
MI  myocardial infarction
OR  odds ratio
PCI  percutaneous coronary intervention
ROC  receiver operating characteristic
SCAI LC  Society for Cardiac Angiography and
Interventions Lesion Classification
Table 1. Univariate Association of Patient Demographic and
Cardiac Risk Factors With In-Hospital Mortality
Factor
% of
Patients
%
Death
Odds
Ratio 95% CI p Value
Age (yr)
50 14.0 0.3 1.00 Ref.
50–59 24.8 0.7 1.99 1.44–2.77  0.0001
60–69 27.0 1.2 3.64 2.67–4.97  0.0001
70–79 25.2 2.2 6.84 5.06–9.25  0.0001
80 8.8 3.8 12.05 8.85–16.43  0.0001
% missing 0.2
Gender
Male 65.9 1.1 1.00 Ref.
Female 34.0 1.9 1.71 1.54–1.90  0.0001
% missing 0.1
Diabetes
No 73.6 1.3 1.00 Ref.
Yes 26.1 1.8 1.41 1.26–1.57  0.0001
% missing 0.4
Hypertension
No 35.8 1.4 1.00 Ref.
Yes 63.8 1.4 1.01 0.90–1.12 0.89
% missing 0.4
Hypercholesterolemia
No 39.2 2.1 1.00 Ref.
Yes 59.1 0.9 0.42 0.38–0.47  0.0001
% missing 1.7
Family history of CAD
No 50.5 1.8 1.00 Ref.
Yes 46.6 1.0 0.56 0.49–0.62  0.0001
% missing 2.9
Current smoking
No 71.8 1.5 1.00 Ref.
Yes 25.6 1.1 0.75 0.66–0.85  0.0001
% missing 2.6
CAD  coronary artery disease; CI  confidence interval; Pts  patients; Ref. 
reference group.
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disease processes (Table 3), angiographic (Table 4) and
procedural (Table 5) factors significantly associated with
mortality that were included in the regression model. Of the
32 variables evaluated, hypertension, previous myocardial
infarction (MI), previous CABG and lesion in a graft did
not achieve a significance level of 0.01 and were not
included in the regression model. Hypercholesterolemia was
also omitted from the model because of its counterintuitive
relationship to the mortality outcome, perhaps related to the
advanced sickness of many of the patients treated. Others
(8,9) also have noted this peculiarity.
A standard training set/test set approach was used. A
randomly generated training set was used to develop the
regression model, and the test set consisting of the remain-
ing patients was used to assess the performance of the model
against observed mortality results. After the risk factors were
determined and their regression weights calculated from the
training set, the standard probability formula was applied to
the test set to determine the risk of mortality for each
patient. The ROC curves were generated for the training set
and the test set.
The model was validated in two ways. First, the dataset
was ordered using the values for each patient’s probability of
mortality generated from the regression model. The dataset
Table 2. Univariate Association of Cardiac History and Anginal
Status With In-Hospital Mortality
Factor
% of
Pts
%
Death
Odds
Ratio 95% CI p Value
Previous PCI
No 67.1 1.6 1.00 Ref.
Yes 32.1 1.0 0.59 0.52–0.67  0.0001
% missing 0.8
Previous CABG
No 77.4 1.5 1.00 Ref.
Yes 18.8 1.2 0.81 0.70–0.94  0.05
% missing 3.8
Remote MI (7 days)
No 69.9 1.4 1.00 Ref.
Yes 28.6 1.4 0.95 0.85–1.07 0.39
% missing 1.5
Current MI
None 68.1 0.5 1.00 Ref.
6 h 10.4 5.1 10.20 8.90–11.68  0.00001
6–24 h 7.4 3.7 7.23 6.16–8.48  0.00001
24 h  7 d 13.4 1.9 3.64 3.09–4.28  0.0001
% missing 0.7
Ejection fraction
50% 52.1 1.2 1.00 Ref.
40%–50% 12.2 0.9 0.81 0.69–0.95  0.01
30%–39% 6.0 1.8 1.55 1.30–1.85  0.0001
20%–29% 2.8 4.4 3.98 3.37–4.70  0.0001
10%–19% 0.5 7.5 6.92 5.65–8.49  0.0001
10% 0.3 10.1 9.60 6.58–14.01  0.00001
% missing or invalid 26.1
Unstable angina
No 36.0 1.7 1.00 Ref.
Yes 61.6 1.3 0.76 0.68–0.94  0.0001
% missing 2.4
CHF class III/IV
No 94.9 1.1 1.00 Ref.
Yes 5.1 7.3 7.03 6.22–7.94  0.00001
CABG  coronary artery bypass graft; CHF  congestive heart failure; CI 
confidence interval; MI  myocardial infarction; PCI  percutaneous coronary
intervention; Pts  patients; Ref.  reference group.
Table 3. Univariate Association of Other Noncoronary Disease
Processes With In-Hospital Mortality
Factor
% of
Pts
%
Death
Odds
Ratio 95% CI p Value
Valvular heart disease
No 96.2 1.3 1.00 Ref.
Yes 3.4 3.9 3.05 2.57–3.62  0.0001
% missing 0.4
Renal disease
No 96.1 1.3 1.00 Ref.
Yes 3.6 5.3 4.36 3.73–5.09  0.00001
% missing 0.3
Peripheral vascular disease
No 87.4 1.3 1.00 Ref.
Yes 12.0 2.2 1.74 1.52–2.00  0.0001
% missing 0.6
Chronic lung disease
No 87.1 1.3 1.00 Ref.
Yes 12.5 2.2 1.68 1.47–1.92  0.0001
% missing 0.4
Cerebrovascular disease
No 90.6 1.3 1.00 Ref.
Yes 9.0 2.4 1.86 1.61–2.16  0.0001
% missing 0.4
CI  confidence interval; Pts  patients; Ref.  reference group.
Table 4. Univariate Association of Angiographic Factors With
In-Hospital Mortality
Factor
% of
Pts
%
Death
Odds
Ratio 95% CI p Value
Disease in 3 vessels
No 73.3 1.1 1.00 Ref.
Yes 24.2 2.6 2.35 2.11–2.62  0.0001
% missing 2.5
Restenosis lesion
No 88.8 1.5 1.00 Ref.
Yes 10.5 1.0 0.65 0.53–0.79  0.0001
% missing 0.7
Occlusion pre-PCI
No 85.3 0.9 1.00 Ref.
Yes 12.2 4.5 5.48 4.92–6.08  0.00001
% missing 2.5
Type C lesion attempted
No 72.6 1.1 1.00 Ref.
Yes 19.4 2.8 2.58 2.31–2.87  0.0001
% missing 8.9
Lesion in a graft
No 90.5 1.4 1.00 Ref.
Yes 7.4 1.5 1.08 0.89–1.31 0.42
% missing 2.1
Left main disease
No 93.0 1.3 1.00 Ref.
Yes 4.7 4.3 3.43 2.94–4.01  0.0001
% missing 2.3
Proximal LAD stenosis
No 62.9 1.1 1.00 Ref.
Yes 34.6 2.1 1.91 1.72–2.13  0.0001
% missing 2.5
CI  confidence interval; LAD  left anterior descending; PCI  percutaneous
coronary intervention; Pts  patients; Ref.  reference group.
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was then divided into deciles of risk, and the observed
mortality rate was calculated for each decile. The observed
versus the expected mortality was plotted and evaluated
using the R-square statistic. The model was also validated
by identifying patient subgroups that were known to have
high mortality rates. In addition, separate logistic regression
models were generated for patients presenting with acute
MI within 24 h of PCI and those presenting without acute
MI within 24 h.
RESULTS
In 100,253 PCI procedures, in-hospital mortality occurred
in 1,422 (1.4%). There was wide variation in mortality
among subgroups of patients, with the highest mortality
rates observed in patients presenting for emergent salvage
procedures (30.9%), PCI indication for shock (28.0%),
insertion of an intra-aortic balloon pump (IABP) pre-PCI
(19.1%) and LVEF 10% (10.1%) (Tables 1–5).
The training set consisted of 50,123 PCI procedures
randomly selected from the overall patient population. In
this group, 707 deaths occurred (1.4%). Multivariate logistic
regression analysis identified PCI indication for shock,
increasing age, the need for urgent or emergent PCI,
pre-procedure placement of an IABP, decreasing LVEF,
acute MI within 24 h of hospital admission, diabetes, renal
failure, chronic lung disease, treatment approaches includ-
ing use of thrombolytics and non-stent devices, and lesion
characteristics including presence of left main or proximal
left anterior descending (LAD) disease and SCAI lesion
class as factors independently associated with in-hospital
mortality (Table 6) with a C-index of 0.89, demonstrating
excellent model discrimination. The Hosmer-Lemeshow
statistic was not significant, indicating little departure from
a perfect fit.
The model was then applied to the test set that consisted
of 50,130 PCI procedures in which 715 deaths occurred
(1.4%). This generated a C-index of 0.89, demonstrating
equally good model discrimination for the test set. The
predicted risks of patients were ranked and divided into
deciles. The number of predicted deaths was plotted against
the number of actual deaths in each decile (Fig. 1). The
computed R-square was 0.96, demonstrating excellent cor-
relation between the expected and observed mortality. Table
7 shows the observed and predicted mortalities, area under
the ROC curve and 95% CIs for the application of the
model to the high-risk groups of patients in the test set. The
predictive model appears to be relatively stable across these
high-risk patients, with areas under the ROC curve exceed-
ing 0.80 in almost every category. The lowest values
occurred in the patients with shock and those undergoing
emergent salvage procedures. A similar finding was reported
by O’Connor et al. (8).
Separate models were developed for patients presenting
with acute MI within 24 h of their PCIs and those
presenting without acute MI. These results are reported in
Tables 8 and 9. The area under the ROC curve was less in
Table 5. Univariate Association of Procedural Factors With In-Hospital Mortality
Factor
% of
Patients
%
Death
Odds
Ratio 95% CI p Value
Presentation—shock
No 97.7 0.9 1.00 Ref.
Yes 1.9 28.0 42.23 37.44–47.63  0.000001
% missing 0.4
Pre PCI-IABP insertion
No 98.4 1.3 1.00 Ref.
Yes 0.5 19.1 17.44 13.82–22.00  0.00001
% missing 1.1
Procedure status
Elective 56.4 0.4 1.00 Ref.
Urgent 29.2 0.9 2.02 1.70–2.41  0.001
Emergent (stable) 12.8 5.8 13.91 12.04–16.07  0.00001
Emergent (salvage) 0.4 30.9 100.26 79.1–127.1  0.000001
% missing 1.2
Stent used
No 23.2 2.1 1.00 Ref.
Yes 74.7 1.2 0.56 0.50–0.62  0.0001
% missing 2.1
GP IIb/IIIa used
No 43.8 1.4 1.00 Ref.
Yes 55.3 1.4 1.04 0.94–1.16 0.47
% missing 0.9
Thrombolytic used
No 91.0 1.3 1.00 Ref.
Yes 7.9 2.9 2.29 1.99–2.65  0.0001
% missing 1.1
CI  confidence interval; GP  glycoprotein; IABP  intra-aortic balloon pump; PCI  percutaneous coronary intervention;
Ref.  reference group.
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Table 6. Multivariate Analysis of Factors Significantly Associated With Mortality: Results in the
Training Dataset (n  50,123)
Factor
Odds
Ratio 95% CI Coefficient p Value
Presentation—shock 8.49 6.99–10.87 2.139  0.0001
Salvage vs. elective 13.38 8.38–21.34 2.594  0.0001
Emergent-stable vs. elective 5.75 4.37–7.57 1.676  0.0001
Urgent vs. elective 1.78 1.39–2.28 0.548  0.0001
IABP placed pre-PCI 1.68 1.08–2.63 0.470  0.05
Age (yrs)
50–59 2.61 1.63–4.20 0.971  0.0001
60–69 3.75 2.38–5.90 1.323  0.0001
70–79 6.44 4.13–10.05 1.866  0.0001
80 11.25 7.10–17.82 2.434  0.0001
Diabetes 1.41 1.10–1.91 0.340  0.001
LVEF
40%–50% 0.87 0.66–1.12 0.172 0.204
30%–39% 0.99 0.74–1.31 0.011 0.939
20%–29% 2.04 1.52–2.75 0.706  0.0001
10%–19% 3.43 2.12–5.54 1.189  0.0001
10% 3.93 1.00–15.41 1.417  0.05
AMI within 24 h 1.31 1.05–1.64 0.270  0.01
SCAI LC
II 1.64 1.28–2.10 0.493  0.0001
III 1.87 1.47–2.38 0.625  0.0001
IV 2.11 1.64–2.70 0.746  0.0001
Left main disease 2.04 1.56–2.66 0.680  0.0001
Proximal LAD lesion 1.97 1.51–2.58 0.263  0.01
Renal failure 3.04 2.33–3.98 1.113  0.0001
Chronic lung disease 1.33 1.09–1.68 0.287  0.01
Use of thrombolytic 1.39 1.09–1.78 0.344  0.01
Use of non-stent device 1.64 1.38–2.00 0.497  0.0001
Constant (intercept)  4.464; Hosmer and Lemeshow goodness of fit chi square  12.442; p  0.133; C-index  0.89.
AMI  acute myocardial infarction; CI  confidence interval; IABP  intra-aortic balloon pump; LAD  left anterior
descending; LVEF  left ventricular ejection fraction; PCI  percutaneous coronary intervention; SCAI LC  Society for
Coronary Angiography and Interventions Lesion Classification.
Figure 1. Plot of observed (x-axis) versus predicted (y-axis) deaths ordered by decile of risk in the training set.
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these models than in the overall model. The C-index for the
analysis of acute MI patients was 0.87 (0.85 to 0.89) and for
non-MI patients was 0.86 (0.83 to 0.88). It is interesting to
note the pattern of factors in each of these models compared
with the overall model. In the model for acute MI patients,
the strongest factors were age, diabetes, left main disease, a
proximal LAD lesion, shock and use of devices other than
stents. Procedures classified as urgent, placement of an
IABP and chronic lung disease were not significant in this
model, and the effects of factors such as LVEF, SCAI lesion
class and classification as an emergent procedure were not as
strong as in the overall model, in which acute MI and
non-MI patients were mixed (Table 8). For patients pre-
senting without MI, presentation in shock, acuteness of the
procedure, pre-placement of an IABP, SCAI lesion class,
renal failure and chronic lung disease emerged as strongly
predictive factors (Table 9). The effects of age, diabetes, left
main disease and the use of devices other than stents were
lesser, while lesions in the proximal LAD and use of
thrombolytic therapy dropped out of the model entirely.
The pattern observed in the acute MI model seems to be
consistent with the highest-risk patients presenting as older,
with diabetes, in shock and having involvement of the left
coronary system. The pattern observed in the non-MI
model seems to be consistent with lesion morphology and
classification of the acuteness of the procedure as being the
factors most related to patient outcome.
DISCUSSION
Over the last decade, advancements in technology and new
pharmaceutical agents have helped to reduce the morbidity
and mortality associated with PCI (20). However, PCI still
carries significant risk, especially in subgroups in which a
more complex clinical condition may lead to higher adverse
event rates. Databases have emerged as tools crucial for
evaluating the quality of cardiac care (21). The ACC–
NCDR provides a way for institutions to collect high-
quality local data and to merge those data with data from
other centers across the country through a national data
registry. The current study demonstrates the potential value
of using this national database for developing a robust
risk-adjustment mortality model for PCI.
Prior risk modeling has been limited by inconsistent
definitions, small sample sizes, lack of institutional diversity,
restricted geographic representation and patient samples
that do not reflect contemporary PCI practice. Hannan et
al. (6) published results from the New York State mandated
registry for PCI. This represented one of the first efforts to
develop a mortality risk model using data from several
centers. The patient sample that was included, however,
reflected an early era in the development of interventional
technology and pharmaceutical treatment. More recently,
Kimmel et al. (7) analyzed the experience in 10,622 first-
time PCI procedures from the Society for Cardiac Angiog-
raphy and Interventions Registry. O’Connor et al. (8)
reported on the development of a risk-adjusted mortality
model using 15,331 patients who underwent PCI over a
three-year period at six regional centers in northern New
England. Although the data definitions and collection
protocols were well-established and produced high-quality
data in both of these studies, the sample sizes were relatively
small for model development. In the Kimmel et al. (7)
study, the geographic distribution was broad, but the
number of centers was small, while the northern New
England experience represented a very narrow geographic
region. Neither of these studies included patient samples
comparable to contemporary PCI cohorts, wherein the
proportion of patients receiving stents and glycoprotein
IIb/IIIa inhibitors exceeds 75%. Two more recent analyses
(13,14) have included patient samples that reflect the
widespread use of stents and glycoprotein IIb/IIIa inhibi-
tors, although both were analyses of a single center’s
experience.
Block et al. (9) combined the experience of eight regis-
tries in a pooled meta-analysis of 158,273 cases to identify
factors associated with risk of Q-wave MI, emergent cardiac
surgery and death. This effort was helpful in providing a
Table 7. Observed and Predicted Mortality and Area Under the
Receiver Operating Characteristic Curve for Selected High Risk
Patient Groups in Test Dataset (50,130)
Patient
Subgroup
Observed/Predicted
Mortality
Area Under
ROC Curve 95% CI
Age (yrs)
50 0.3/0.4 0.91 0.85–0.96
50–59 0.7/0.9 0.91 0.87–0.95
60–69 1.2/1.1 0.88 0.84–0.91
70–79 2.2/2.0 0.86 0.84–0.89
80 3.8/3.2 0.82 0.78–0.86
LVEF
50% 1.1/1.2 0.89 0.87–0.91
40%–50% 1.3/1.4 0.88 0.84–0.92
30%–39% 2.8/2.3 0.86 0.82–0.90
20%–29% 6.1/4.7 0.84 0.79–0.88
20% 9.9/7.5 0.86 0.81–0.92
Acuteness of PCI
Elective 0.5/0.2 0.83 0.79–0.86
Urgent 0.9/1.1 0.82 0.78–0.85
Emergent 5.9/4.1 0.86 0.84–0.87
Salvage 29.2/19.7 0.80 0.74–0.87
Renal failure 5.2/4.4 0.83 0.78–0.87
Shock 27.2/12.5 0.73 0.69–0.76
Female gender 1.8/1.6 0.87 0.85–0.89
Diabetes 1.8/1.7 0.90 0.88–0.92
Lesion type
Type C 2.8/2.4 0.89 0.87–0.91
Non-C lesion 1.1/1.2 0.89 0.87–0.92
Treatment
Stent used 1.2/1.1 0.89 0.87–0.92
No stent used 2.0/1.8 0.89 0.87–0.92
AMI
Within 6 h 4.9/4.7 0.87 0.85–0.89
Within 24 h 4.5/4.4 0.88 0.87–0.90
AMI  acute myocardial infarction; CI  confidence interval; LVEF  left
ventricular ejection fraction; PCI  percutaneous coronary intervention; ROC 
receiver operating characteristic.
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broad view of data elements across a large sample of
patients. It was limited for the purpose of model develop-
ment, however, in that source data were not available to
apply standard statistical analyses. Other efforts, such as the
multi-center study of Ellis et al. (10), the National Heart,
Lung, and Blood Percutaneous Transluminal Coronary
Angioplasty registries (11) and the New Approaches in
Coronary Intervention Registry (12), have utilized risk-
adjustment techniques. However, the centers involved in
these studies were highly selective and not necessarily
representative of a broad assessment of PCI experience.
Comparison with models from other studies. The vari-
ables that were generated from the ACC–NCDR mortality
model are consistent with a number of other studies
published from local databases and registries. O’Connor et
al. (8) identified increasing age, cardiogenic shock, urgent
and emergent procedures, LVEF, pre-procedure IABP
placement and attempt of type C lesions as significant
predictors in their model. They also noted that heart failure
and creatinine levels 2.0 mg/dl were predictors in their
model, but these two variables were not included in the
analysis of the ACC–NCDR experience, although the
definition of renal failure in the current analysis was based
on similar creatinine levels. The ACC–NCDR data analysis
included usage of devices, which was not addressed in the
O’Connor et al. (8) model. The only factor common to both
studies that was significant in the O’Connor et al. (8) model
and that fell out of the ACC–NCDR model was the
presence of peripheral vascular disease. In an analysis of
patients undergoing more contemporary PCI, Resnic et al.
(13) identified similar factors, including cardiogenic shock,
class 3 or 4 heart failure, left main intervention, tachycardia,
chronic renal insufficiency, age 75 years, type B2 or C
lesions, acute MI, unstable angina and stent use (a negative
relationship to mortality).
Block et al. (9) pooled data from eight different sources
and identified a number of factors associated with in-
hospital death. Variables they identified that overlap with
the current analysis include age, LVEF, acute MI, proce-
dure acuteness, cardiogenic shock, use of IABP, diabetes,
renal failure and lesion type. There is remarkable consis-
tency for many of the factors across all databases.
Other studies have focused on the unique relationship of
lesion factors to adverse outcomes. Ellis et al. (14) found 10
lesion factors that were related to ischemic complications
after PCI. The most significant factors were a non-chronic
total occlusion and degenerated saphenous vein graft. In the
current analysis, the SCAI LC lesion classification com-
bined the effect of type C and occlusion. However, treat-
ment of a lesion in a vein graft did not have a significant
Table 8. Multivariate Analysis of Factors Significantly Associated With Mortality for Patients
With Acute Myocardial Infarction Within 24 h: Results in the Training Dataset (n  8,921)
Factor
Odds
Ratio 95% CI Coefficient p Value
Presentation—shock 8.70 6.75–11.22 2.163  0.0001
Salvage vs. elective 6.65 3.70–11.94 1.895  0.0001
Emergent stable vs. elective 2.43 1.58–3.74 0.888  0.0001
Urgent vs. elective 0.86 0.50–1.48 0.149 0.862
IABP placed pre-PCI 0.78 0.40–1.23 0.122 0.124
Age (yrs)
50–59 2.96 1.63–5.38 1.086  0.0001
60–69 4.27 2.41–7.58 1.453  0.0001
70–79 7.45 4.25–13.07 2.008  0.0001
80 12.20 6.75–22.05 2.501  0.0001
Diabetes 1.54 1.19–2.00 0.433  0.001
LVEF
40%–50% 0.79 0.56–1.13 0.227 0.202
30%–39% 0.97 0.67–1.39 0.036 0.848
20%–29% 1.53 1.02–2.29 0.424  0.05
10%–19% 2.33 1.16–4.67 0.845  0.01
10% 1.54 0.12–20.23 0.431 0.742
SCAI LC
II 0.93 0.60–1.44 0.073 0.744
III 1.33 0.98–1.79 0.283 0.062
IV 1.54 1.13–2.10 0.428  0.01
Left main disease 2.16 1.49–3.13 0.769  0.0001
Proximal LAD lesion 1.54 1.22–1.94 0.432  0.01
Renal failure 2.61 1.95–3.49 0.959  0.0001
Chronic lung disease 0.48 0.29–1.01 0.021 0.488
Use of thrombolytic 1.37 1.04–1.80 0.314  0.01
Use of nonstent device 1.78 1.38–2.50 0.510  0.0001
Constant (intercept)  3.746; Hosmer and Lemeshow goodness of fit chi square  6.891; p  0.548; C-index  0.87.
CI  confidence interval; IABP  intra-aortic balloon pump; LAD  left anterior descending; LVEF  left ventricular
ejection fraction; PCI  percutaneous coronary intervention; SCAI LC  Society for Cardiac Angiography and Interventions
Lesion Classification.
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relationship to in-hospital mortality. The assessment of vein
graft irregularities in the Ellis et al. (14) study probably
represents a more comprehensive analysis of the condition
of the saphenous vein graft, which may have enhanced the
predictive utility of this variable. Zaacks et al. (22) found
that focused characteristics of lesions (presence of thrombus,
inability to protect a side branch and degenerated vein graft
lesions) were more likely to be related to complications,
while the more general classification of lesions using the
ACC/AHA A-B-C system were more predictive of proce-
dural success. Several lesion factors that are consistent with
other studies emerged in the current analysis as predictors of
mortality. One of the most important aspects of the current
analysis, however, is the development of separate models for
acute MI and non-MI patients. This analysis showed that
lesion factors were more highly predictive of in-hospital
mortality for non-MI patients than for acute-MI patients.
The utility of risk models. It is important to emphasize
that the development of predictive models is as much an art
as it is a science. Models are dependent on the quality and
accuracy of the data and the relative rate of the outcome
event being studied. If the quality of the data is suspect, the
modeling process is unpredictable. Likewise, when the
outcomes assessed occur infrequently, as in PCI mortality,
the modeling process is even more challenging. These
limitations of modeling must be kept in mind when evalu-
ating and applying the results of the models presented
herein as well as other models developed for PCI outcomes.
Study limitations. There were variables in the ACC–
NCDR that could not be reliably used for the current
analysis. The variable for assessing the status of congestive
heart failure had uninterpretable data resulting from a
software vendor problem. This problem was corrected, and
the heart failure variable will be available for future analyses.
The logistic regression approach has an upper limit of
predictive capability, with a C-statistic of around 0.87 (23).
Techniques such as neural networks are capable of achieving
indexes to 0.93 and may play a role in future modeling
efforts. It is also not clear to what extent these models built
on national datasets can be generalized to local datasets.
Comparisons of several models used in cardiac surgery have
demonstrated similar predictive capabilities (24,25), but
application from one setting to another has limitations (26).
These same issues are present for risk-adjusted models
developed for PCI mortality.
Perhaps the most significant limitation of the current
study is the lack of a systematic approach to auditing the
data. Although many consistency checks were instituted in
Table 9. Multivariate Analysis of Factors Significantly Associated With Mortality for Patients
With No Acute Myocardial Infarction Within 24 h: Results in the Training Dataset
(n  41,202)
Factor
Odds
Ratio 95% CI Coefficient p Value
Presentation—shock 10.43 6.90–15.75 2.344  0.0001
Salvage vs. elective 13.58 4.55–40.55 2.609  0.0001
Emergent-stable vs. elective 6.93 4.89–9.80 1.935  0.0001
Urgent vs. elective 1.88 1.42–2.49 0.633  0.0001
IABP placed pre-PCI 2.27 1.02–5.08 0.820  0.05
Age (yrs)
50–59 2.30 1.04–5.07 0.833  0.05
60–69 3.20 1.51–6.81 1.164  0.01
70–79 5.72 2.73–11.94 1.743  0.0001
80 10.84 5.11–22.98 2.383  0.0001
Diabetes 1.29 0.99–1.67 0.251  0.05
LVEF
40%–50% 0.90 0.60–1.35 0.227 0.616
30%–39% 1.02 0.64–1.63 0.036 0.929
20%–29% 3.00 1.98–4.51 0.424  0.00001
10%–19% 4.71 2.50–8.89 0.845  0.00001
10% 6.54 1.53–27.94 0.431  0.01
SCAI LC
II 2.25 1.66–3.05 0.810  0.0001
III 2.59 1.74–3.85 0.952  0.0001
IV 2.85 1.92–4.22 1.046  0.0001
Left main disease 1.85 1.26–2.74 0.613  0.01
Proximal LAD lesion 0.95 0.54–1.32 0.142 0.235
Renal failure 3.62 2.59–5.07 1.287  0.0001
Chronic lung disease 1.55 1.14–2.10 0.437  0.01
Use of thrombolytic 0.50 0.02–0.06 0.049 0.484
Use of nonstent device 1.58 1.24–2.04 0.462  0.001
Constant (intercept)  4.025; Hosmer and Lemeshow goodness of fit chi square  13.530; p  0.095; C-index  0.86.
CI  confidence interval; IABP  intra-aortic balloon pump; LAD  left anterior descending; LVEF  left ventricular
ejection fraction; PCI  percutaneous coronary intervention; SCAI LC  Society for Cardiac Angiography and Interventions
Lesion Classification.
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the data collection process, the extent to which these data
reflect clinical reality at each institution is not known. It is
imperative that future databases used for institutional eval-
uation be subjected to valid and objective audit processes.
CONCLUSIONS
This study represents the development of a risk-adjustment
model for in-hospital mortality after PCI in a large, con-
temporary, multi-institutional national database. This anal-
ysis has generated a powerful tool for evaluating and
comparing mortality outcomes across institutions, which is
crucial in the current era of cardiovascular intervention.
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